Which partially indicate SL-XM inhibits M1 macrophage polarization through NF-κB and MAPK signaling pathway, thereby reducing inflammation and alleviating RA symptoms (Figure 7F). This evidence concerns the gene NFKB1 and rheumatoid arthritis.